Strong inflow of foreign capital is another trend vane: Middle Eastern tycoons increase their presence in China, and multinational sovereign wealth funds continue to lay out A-shares
① The Abu Dhabi Investment Authority and the Kuwait Investment Authority held a large number of A-share listed companies in the first quarter; ② the Middle East Sovereign Fund also stepped up research on A-shares ③ Other overseas sovereign wealth funds are increasing their layout in the Chinese market.
Express News | Jiangsu's imports and exports to Hungary increased 16.5% year-on-year in the first quarter
Express News | Waigaoqiao established a biomedical industry company with a registered capital of 200 million
Express News | Huabang Health: The company's shareholding companies are involved in cell therapy and stem cell-related businesses
Express News | Shanghai Customs clears import channels for R&D materials to support biomedical companies to speed up R&D innovation and increase efficiency
Express News | The CXO industry quarterly report is polarized and clearly segmented, sending a signal of recovery
Express News | Sinopharm Hyundai: Currently not involving biomedicine and synthetic organisms
Express News | Kexon Pharmaceuticals establishes a biomedical subsidiary in Guangzhou
Express News | More than 540 enterprises certified by Shanghai Customs: contributing more than one-third of Shanghai's imports and exports
Express News | Haizheng Pharmaceutical invests in innovative drug research enterprise Vanosi
Express News | Shanghai and Hong Kong have reached a series of major science and innovation cooperation results involving fields such as artificial intelligence
Express News | The three regions of Beijing, Tianjin and Hebei will join hands to promote collaborative innovation and development of the biomedical industry
Express News | Kanglong Chemical: Currently, we have not seen the impact of the Biomedicine Act on customer acquisition
Express News | The first Global Investment Promotion Conference was held in Suzhou, Jiangsu to attract 367 project contracts
Express News | Kangenbei's innovative traditional Chinese medicine yellow holly flower flavonoid oral patch received a reward of 10 million yuan from the government
Express News | The 2024 Suzhou Global Investment Promotion Conference theme conference was held and a total investment of about 372 billion yuan was signed
Express News | Investing in Xingmeng Biotech, Kexon Biotech enters a new field of innovative antibody drugs
Express News | Unnamed Medicine Receives Letter of Concern: Failure to disclose related parties and non-operating related transactions in accordance with regulations
Express News | 2024 Quzhou (Shanghai) Investment Promotion Conference will be held
Express News | The SCO Demonstration Zone creates an open highland to attract settlement with a maximum reward of 150 million yuan